An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.
Saved in:
| Title: | An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program. |
|---|---|
| Authors: | Guerrini R; Children's Hospital A Meyer, University of Florence, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Florence, Italy., Specchio N; Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesù Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy., Aledo-Serrano Á; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain., Pringsheim M; Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik, Vogtareuth, Germany.; Department for Congenital Heart Disease and Pediatric Cardiology, German Heart Center, Munich, Germany.; Research Institute for Rehabilitation, Transition and Palliation, Paracelsus Medical University, Salzburg, Austria., Darra F; Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Verona, Italy., Mayer T; Epilepsy Center Kleinwachau, Dresden-Radeberg, Germany., Gil-Nagel A; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain., Polster T; Krankenhaus Mara - Bethel Epilepsy Centre, Department of Epileptology, Medical School, Bielefeld University, Bielefeld, Germany., Zuberi SM; Paediatric Neurosciences Research Group, Royal Hospital for Children & Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK., Lothe A; Zogenix International, Maidenhead, UK., Gammaitoni A; Zogenix, Inc., Emeryville, California, USA., Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Goethe-University Frankfurt, Frankfurt am Main, Germany. |
| Source: | Epilepsia open [Epilepsia Open] 2022 Dec; Vol. 7 (4), pp. 578-587. Date of Electronic Publication: 2022 Aug 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101692036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9239 (Electronic) Linking ISSN: 24709239 NLM ISO Abbreviation: Epilepsia Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35801621 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guerrini+R%22">Guerrini R</searchLink>; Children's Hospital A Meyer, University of Florence, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Specchio+N%22">Specchio N</searchLink>; Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesù Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Aledo-Serrano+Á%22">Aledo-Serrano Á</searchLink>; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pringsheim+M%22">Pringsheim M</searchLink>; Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik, Vogtareuth, Germany.; Department for Congenital Heart Disease and Pediatric Cardiology, German Heart Center, Munich, Germany.; Research Institute for Rehabilitation, Transition and Palliation, Paracelsus Medical University, Salzburg, Austria.<br /><searchLink fieldCode="AU" term="%22Darra+F%22">Darra F</searchLink>; Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Mayer+T%22">Mayer T</searchLink>; Epilepsy Center Kleinwachau, Dresden-Radeberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gil-Nagel+A%22">Gil-Nagel A</searchLink>; Epilepsy Program, Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Polster+T%22">Polster T</searchLink>; Krankenhaus Mara - Bethel Epilepsy Centre, Department of Epileptology, Medical School, Bielefeld University, Bielefeld, Germany.<br /><searchLink fieldCode="AU" term="%22Zuberi+SM%22">Zuberi SM</searchLink>; Paediatric Neurosciences Research Group, Royal Hospital for Children & Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Lothe+A%22">Lothe A</searchLink>; Zogenix International, Maidenhead, UK.<br /><searchLink fieldCode="AU" term="%22Gammaitoni+A%22">Gammaitoni A</searchLink>; Zogenix, Inc., Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Strzelczyk+A%22">Strzelczyk A</searchLink>; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Goethe-University Frankfurt, Frankfurt am Main, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101692036%22">Epilepsia open</searchLink> [Epilepsia Open] 2022 Dec; Vol. 7 (4), pp. 578-587. <i>Date of Electronic Publication: </i>2022 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101692036 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2470-9239 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224709239%22">24709239 </searchLink><i>NLM ISO Abbreviation: </i>Epilepsia Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35801621 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/epi4.12624 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 578 Titles: – TitleFull: An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guerrini R – PersonEntity: Name: NameFull: Specchio N – PersonEntity: Name: NameFull: Aledo-Serrano Á – PersonEntity: Name: NameFull: Pringsheim M – PersonEntity: Name: NameFull: Darra F – PersonEntity: Name: NameFull: Mayer T – PersonEntity: Name: NameFull: Gil-Nagel A – PersonEntity: Name: NameFull: Polster T – PersonEntity: Name: NameFull: Zuberi SM – PersonEntity: Name: NameFull: Lothe A – PersonEntity: Name: NameFull: Gammaitoni A – PersonEntity: Name: NameFull: Strzelczyk A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2470-9239 Numbering: – Type: volume Value: 7 – Type: issue Value: 4 Titles: – TitleFull: Epilepsia open Type: main |
| ResultId | 1 |
